Alliance Wealth Advisors, LLC /UT

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1893261 Centerville, UT

Position in HALO

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$610,662

+$6,760 QoQ

Shares Held

7,802

-16.5% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

#361

of 664 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Alliance Wealth Advisors, LLC /UT holds $2,238,891 across 5 Biotechnology names. HALO ranks #1 (27.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc. This page	7,802	$610,662
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,157	$574,716
3	LGND	Ligand Pharmaceuticals Inc	1,772	$560,111
4	REGN	Regeneron Pharmaceuticals, Inc.	442	$275,604
5	KRYS	Krystal Biotech, Inc.	586	$217,798

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$610,662	7,802	-16.5%	Shares	Other	2026-07-23
2026-03-31	$603,902	9,344	-25.8%	Shares	Sole	2026-05-12
2025-12-31	$847,441	12,592	-30.2%	Shares	Sole	2026-02-02
2025-09-30	$1,323,200	18,042	-5.4%	Shares	Sole	2025-11-10
2025-06-30	$991,761	19,065	-7.2%	Shares	Sole	2025-08-14
2025-03-31	$1,310,593	20,539	+0.4%	Shares	Sole	2025-05-13
2024-12-31	$978,336	20,463	+2.9%	Shares	Sole	2025-01-24
2024-09-30	$1,138,675	19,893	+47.1%	Shares	Sole	2024-11-08
2024-06-30	$708,273	13,527	+9.8%	Shares	Sole	2024-08-02
2024-03-31	$500,974	12,315	+28.1%	Shares	Sole	2024-05-13
2023-12-31	$355,185	9,610	+14.6%	Shares	Sole	2024-02-05
2023-09-30	$320,459	8,389	+7.4%	Shares	Sole	2023-11-09
2023-06-30	$281,634	7,808	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.